Nicotine Dependence: Biology, Behavior, and Treatment
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Despite great advances in the understanding and treatment of nicotine dependence, close to 21% of adults in the United States continue to smoke. Tobacco use is the single greatest cause of premature and preventable death in the United States. This article reviews the epidemiology, assessment, neurobiology, genetic etiology, and treatment of nicotine dependence. Enhanced understanding of these dimensions of nicotine dependence may help to advance progress toward lowering the prevalence rate of tobacco use in the U.S. and lowering the rate of tobacco-related morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation
Jorenby, D. E., Leischow, S. J., Nides, M. A., Rennard, S. I., Johnston, J. A., Hughes, A. R., Smith, S. S., Muramoto, M. L., Daughton, D. M., Doan, K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903043400903 · Cited by 1,585 · cited 17×
“Polymorphisms in CYP2A6, a nicotine-metabolizing enzyme, have been associated with NRT usage and treatment levels of nicotine among smokers receiving transdermal nicotine treatment (40).”
BackgroundInfluentialIs there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388 · cited 3×
“The dopaminergic system, considered the common pathway of drug dependence (10), has also been a target of research on nicotine dependence genetics.”
BackgroundInfluentialAntidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Varenicline: An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation
Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J., Sands, S. B., Davis, T. I., Lebel, L. A., Fox, C. B., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050069n · Cited by 930
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl438 · Cited by 850 · cited 1×
“Associations have been reported between nicotine dependence and variants in CHRNA4 (encoding the α4 receptor subunit) (42, 43), as well as CHRNA5 and CHRNA3 (encoding the α5 and α3 subunits) (44, 45).”
BackgroundNicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Nicotine receptor partial agonists for smoking cessation
Cahill, K., Stead, L., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006103.pub2 · Cited by 747
Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas
Mansvelder, H. D., Keath, J. R., & McGehee, D. S. (2002) · Neuron · doi:10.1016/s0896-6273(02)00625-6 · Cited by 701 · cited 1×
“The nAChRs located on the GABA-ergic neurons are of the α4β2 subtype (16) and desensitize quickly, whereas the presynaptic nAChRs located on the glutamatergic terminals have the α7 subunit (17) and are slower to desensitize (18).”
BackgroundKlink, R., d'Exaerde, A. D. K., Zoli, M., & Changeux, J.-P. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01452.2001 · Cited by 674
Cited by
Drugs as instruments: A new framework for non-addictive psychoactive drug use
Müller, C. P., & Schumann, G. (2011) · Behavioral and Brain Sciences · doi:10.1017/s0140525x11000057 · Cited by 286
Mackey, S., Allgaier, N., Chaarani, B., Spechler, P., Orr, C., Bunn, J., Allen, N. B., Alia-Klein, N., Batalla, A., Blaine, S., et al. (2019) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.17040415 · Cited by 266
Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment
Ashare, R. L., Falcone, M., & Lerman, C. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.034 · Cited by 170
“Yet quitting smoking is difficult, even with FDA approved pharmacotherapies (Ray et al., 2009b).”
Self-citationThe cessation and detoxification effect of tea filters on cigarette smoke
Yan, J., Di, X., Liu, C., Zhang, H., Huang, X., Zhang, J., Zhao, Y., Zhang, L., Chang, Y., Liang, Y., et al. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0097-1 · Cited by 10
Metadata
- Authors
- Ray, R., Schnoll, R. A., & Lerman, C.
- Venue
- Annual Review of Medicine
- Publisher
- Annual Reviews
- Published
- 2009-02-01
- Volume
- 60
- Issue
- 1
- Pages
- 247-260
- ISSN
- 0066-4219 (ISSN-L)
- 1545-326X
- OpenAlex
- W2115391658
- Cited by
- 57
- References
- 29
- FWCI
- 0.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nicotine Dependence: Biology, Behavior, and Treatment. https://app.cochat.ai/papers/10.1146/annurev.med.60.041707.160511
- The paper
- Ray, R., Schnoll, R. A., & Lerman, C. (2009). Nicotine Dependence: Biology, Behavior, and Treatment. Annual Review of Medicine. https://doi.org/10.1146/annurev.med.60.041707.160511
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.